Phenotype under study | Experimental condition | Method(s) of detection | Gene(s) identified | Reference(s) | ||||
---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | |||
 | X | X | X |  | X | QTL mapping (ISA) plus microarray | ABZ1 | [76] |
X | Â | Â | X | X | X | MHA | ADE5,7, ARO8, VBA3 | [40] |
 |  | X | X |  | X | QTL mapping (BSA) | ARG8, BIO3, GCN1, MDS3 | [82] |
 | X |  | X |  | X | QTL mapping (ISA) | AGP1, ASI1, GLT1 | [41] |
X | Â | Â | Â | X | Â | QTL mapping (ISA) | DAL1, DAL4, RIM15, PUT4 | [48] |
 | X | X | X | X | X | QTL mapping (ISA) | RIM15 | [42] |
 | X |  | X |  | X | ASE plus ASB | ASN1 | [90] |
 |  | X | X |  | X | ASE | GDB1 | [91] |
 | X |  | X |  | X | QTL mapping (ISA) plus BSR-seq | ARO1, ALP1, ASI2, CPS1, EAP1, GTR1, LYP1, NPR1, PDC1, RPI1, SAP185, SCH9, SIT4, TOR2 | |
 |  | X |  | X | X | WYDC | AAT2, BRO1, EAR1, MFA2, MMS2, MRP17, MVB12, TPK2, UBC13, UBI4, UBP7 | [89] |
 |  | X | X | X | X | QTL mapping (ISA) | KAE1 | [84] |